Recent studies validate blood biomarkers like p-tau217 for predicting Alzheimer’s onset within 3-4 years at 94% accuracy, enabling early interventions but raising ethical and socioeconomic conce...
Recent advances in partial cellular reprogramming using OSKM factors show promise in extending healthspan and treating age-related diseases, with biotech firms accelerating towards human trials. New r...
Recent UK Biobank analysis shows healthy dietary patterns can extend lifespan by 1.5-3.0 years, emphasizing diet as a key modifiable factor for longevity and healthspan extension. New data from UK Bio...
A new blood test based on p-tau217 biomarker can predict Alzheimer’s symptom onset in 3-4 years with high accuracy, offering early intervention opportunities. Recent studies validate a p-tau217 ...
New evidence supports menopausal hormone therapy for reducing mortality and enhancing healthspan, with updated guidelines emphasizing personalized approaches based on recent studies and expert insight...
Recent ethical debates in longevity science highlight public support for life extension with equity, expert calls for transparency, and policy integration to address ageism and access disparities. Adv...
New research reveals Ube2g1 upregulation in hematopoietic stem cells drives immune senescence via tyrosine phosphorylation, offering insights for reversing age-related decline, based on Haematologica ...
Cornell University research reveals white fat can generate heat via uncoupling, offering a potential complementary therapy to GLP1 agonists for obesity, with recent discussions at conferences highligh...
Recent research shows targeted removal of dysfunctional B cells in aged mice improves immune function and healthspan, suggesting new therapeutic avenues for combating age-related decline. A new study ...
Emerging research links aging oral microbiome with senescent cells to amplify systemic inflammation, driving diseases like Alzheimer’s and offering new intervention targets such as probiotics an...
